tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Legend Biotech price target lowered to $54 from $60 at UBS
PremiumThe FlyLegend Biotech price target lowered to $54 from $60 at UBS
25d ago
Promising Outlook for Legend Biotech’s CARVYKTI: Buy Rating Affirmed by Mitchell Kapoor
Premium
Ratings
Promising Outlook for Legend Biotech’s CARVYKTI: Buy Rating Affirmed by Mitchell Kapoor
25d ago
Legend Biotech’s CAR T Cell Therapies See FDA REMS Removal and EMA Label Update
Premium
Company Announcements
Legend Biotech’s CAR T Cell Therapies See FDA REMS Removal and EMA Label Update
26d ago
Legend Biotech Reveals 5-Year Survival Data for CARVYKTI® at ASCO 2025
PremiumCompany AnnouncementsLegend Biotech Reveals 5-Year Survival Data for CARVYKTI® at ASCO 2025
2M ago
Legend Biotech unveils five-year survival data fro CARVYKTI
Premium
The Fly
Legend Biotech unveils five-year survival data fro CARVYKTI
2M ago
Buy Rating for Legend Biotech Driven by Carvykti’s Market Position and Efficacy
Premium
Ratings
Buy Rating for Legend Biotech Driven by Carvykti’s Market Position and Efficacy
2M ago
Legend Biotech’s Earnings Call Highlights Growth and Optimism
PremiumCompany AnnouncementsLegend Biotech’s Earnings Call Highlights Growth and Optimism
2M ago
Legend Biotech Secures New Headquarters in Bridgewater
Premium
Company Announcements
Legend Biotech Secures New Headquarters in Bridgewater
2M ago
Legend Biotech price target lowered to $71 from $88 at Truist
Premium
The Fly
Legend Biotech price target lowered to $71 from $88 at Truist
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100